Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma.
Mona MohammadRichard M AndrewsP Nicholas PlowmanGordon HayAmit K AroraVictoria M L CohenMandeep S SagooPublished in: The British journal of ophthalmology (2020)
Intravitreal MTX was a safe and effective treatment modality for relapsed PIOL after systemic chemotherapy and radiotherapy, achieving local tumour control in 89%, and hence represents an optimal choice. However, given the rare nature of PIOL, larger collaborative studies with longer follow-up are needed to corroborate this.
Keyphrases
- diffuse large b cell lymphoma
- acute lymphoblastic leukemia
- vascular endothelial growth factor
- acute myeloid leukemia
- multiple myeloma
- hodgkin lymphoma
- locally advanced
- diabetic retinopathy
- age related macular degeneration
- early stage
- optical coherence tomography
- radiation therapy
- cataract surgery
- high dose
- radiation induced
- type diabetes
- adipose tissue
- combination therapy
- endothelial cells
- decision making